Key result
HRVB offers a practical alternative to medications for treating stress and depression.
Why the study?
Medications frequently used to treat stress and depression can affect metabolism, creating a need for alternative interventions to replace or minimize drug use.
Does heart rate variability biofeedback improve stress and depression compared to medications?
Does heart rate variability biofeedback improve stress and depression compared to medications?
Heart rate variability biofeedback is reviewed as a potential non-pharmacological alternative for managing stress and depression.
HRV biofeedback should not yet change practice for stress and depression; leaves open need for RCTs versus medications.
Depression is prevailing and captivating millions of individuals across the globe. There are numerous stressors and triggers that can induce depressive symptoms or anxiety in individuals of all ages. This exponential growth in depressed and distressed members of society may lead to a massive loss of productive individuals. It is a general practice to prescribe drugs to treat such psychological concerns, but acquiring these medications frequently may affect the body's metabolism. Alternative interventions that can replace or minimize the use of drugs are needed. Heart rate variability biofeedback (HRVB) is a practical approach to treating stress and depression. This article intends to represent an overview of HRVB, its effectiveness, and its side effects so that it can be compared to the medications prescribed.
No takes yet. Share an insight, caveat, or question.
Batool et al. (2022) conducted a review in Stress and depression. Heart rate variability biofeedback (HRVB) vs. Medications was evaluated. Heart rate variability biofeedback is reviewed as a practical alternative to medications for treating stress and depression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: